Vivoryon Therapeutics Statistics

Total Valuation

AMS:VVY has a market cap or net worth of EUR 38.20 million. The enterprise value is 32.66 million.

Market Cap	38.20M
Enterprise Value	32.66M

Important Dates

The last earnings date was Thursday, April 23, 2026.

Earnings Date	Apr 23, 2026
Ex-Dividend Date	n/a

Share Statistics

AMS:VVY has 29.61 million shares outstanding. The number of shares has increased by 2.92% in one year.

Current Share Class	29.61M
Shares Outstanding	29.61M
Shares Change (YoY)	+2.92%
Shares Change (QoQ)	+5.34%
Owned by Insiders (%)	8.32%
Owned by Institutions (%)	10.19%
Float	25.26M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	8.08
P/TBV Ratio	9.72
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.69
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.86

Financial Position

The company has a current ratio of 7.68, with a Debt / Equity ratio of 0.02.

Current Ratio	7.68
Quick Ratio	6.75
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.01
Interest Coverage	-189.62

Financial Efficiency

Return on equity (ROE) is -140.45% and return on invested capital (ROIC) is -86.92%.

Return on Equity (ROE)	-140.45%
Return on Assets (ROA)	-59.25%
Return on Invested Capital (ROIC)	-86.92%
Return on Capital Employed (ROCE)	-133.39%
Weighted Average Cost of Capital (WACC)	12.20%
Revenue Per Employee	n/a
Profits Per Employee	-632,357
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.49% in the last 52 weeks. The beta is 1.43, so AMS:VVY's price volatility has been higher than the market average.

Beta (5Y)	1.43
52-Week Price Change	-28.49%
50-Day Moving Average	1.35
200-Day Moving Average	1.50
Relative Strength Index (RSI)	40.74
Average Volume (20 Days)	34,874

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-8.91M
Pretax Income	-8.85M
Net Income	-8.85M
EBITDA	-8.77M
EBIT	-8.91M
Earnings Per Share (EPS)	-0.33

Full Income Statement

Balance Sheet

The company has 5.65 million in cash and 108,000 in debt, giving a net cash position of 5.54 million or 0.19 per share.

Cash & Cash Equivalents	5.65M
Total Debt	108,000
Net Cash	5.54M
Net Cash Per Share	0.19
Equity (Book Value)	4.73M
Book Value Per Share	0.17
Working Capital	5.59M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.46 million and capital expenditures -6,000, giving a free cash flow of -8.46 million.

Operating Cash Flow	-8.46M
Capital Expenditures	-6,000
Depreciation & Amortization	147,000
Net Borrowing	-61,000
Free Cash Flow	-8.46M
FCF Per Share	-0.29

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AMS:VVY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.92%
Shareholder Yield	-2.92%
Earnings Yield	-23.17%
FCF Yield	-22.15%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2